0001607062-16-000684.txt : 20160216 0001607062-16-000684.hdr.sgml : 20160215 20160216170352 ACCESSION NUMBER: 0001607062-16-000684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160216 FILED AS OF DATE: 20160216 DATE AS OF CHANGE: 20160216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brusegard David CENTRAL INDEX KEY: 0001516920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 161430009 MAIL ADDRESS: STREET 1: 4145 NORTH SERVICE ROAD, SUITE 200 CITY: BURLINGTON STATE: A6 ZIP: L7L6A3 4 1 brusegard021616form4.xml FORM 4 X0306 4 2016-02-16 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001516920 Brusegard David 4145 NORTH SERVICE ROAD, SUITE 200 BURLINGTON A6 L7L6A3 ONTARIO, CANADA 0 1 0 0 Chief Operating Officer Common Stock 2016-02-16 4 M 0 1667671 0.001 A 5615070 D Common Stock Purchase Option 0.001 2016-02-16 4 M 0 1667671 0 D 2016-02-09 2020-10-26 Common Stock 1667671 0 D /s/ Dr. David Brusegard, PhD 2016-02-16